GeneNews in pact for first personalized medicine center in China

GeneNews (TSX:GEN) has signed a memorandum of understanding with Shanghai Biochip, a leading Chinese engineering center for advanced microarray and gene expression profiling technologies, for a strategic alliance to establish the first Sentinel Centre for Personalized Medicine in China. GeneNews and SBC would jointly establish and manage the Sentinel Centre for Personalized Medicine to co-develop [...]

GeneNews platform identifies blood biomarkers for NPC

In a presentation at the 2011 Asia Pacific Cancer Conference, GeneNews (TSX:GEN) reported that a study using its proprietary Sentinel Principle platform technology identified blood-based biomarkers that distinguished nasopharyngeal carcinoma (NPC) patients from controls and from patients with other cancers with high accuracy. NPC is a common cancer in certain parts of Northern Africa and [...]

Schizophrenia biomarkers found by GeneNews’ Sentinel Principle

A study using GeneNews’ (TSX:GEN) Sentinel Principle platform technology to identify complex changes in blood gene expression patterns that may be indicative of underlying risk factors for schizophrenia will be published in the American Journal of Medical Genetics Part B and is currently available online. “This study shows that we can identify a gene signature [...]

GeneNews technology able to predict risk of liver cancer for patients with chronic hepatitis

A poster entitled “Biomarkers to predict risk of subsequent hepatocellular cancer in patients with chronic hepatitis,” describing the initial phase of analysis of a 1,600-cohort study using GeneNews’ (TSX:GEN) Sentinel Principle, was presented at the 9th Liver Update 2011 conference in Malaysia. The poster reports on the application of the Sentinel Principle platform technology to [...]

Prescription for growth

We, at biotuesdays.com, attended Dundee Capital Markets’ second emerging growth conference last week, where over 20 technology, life sciences and industrial growth companies presented. Dundee specializes in early-stage growth, and to say that the one-day showcase was jammed full of investment ideas is a bit of understatement. Here’s a sampling of what we took away [...]

Second U.S. patent awarded to GeneNews

GeneNews (TSX:GEN) was granted a second U.S. patent for its core Sentinel Principle platform technology, covering its application in any health management context, including diagnosis, staging of disease, drug testing, monitoring response to treatment and biomarker screening. “Together, these two patents form a strong foundation for our IP, protecting the application of our Sentinel Principle [...]